Understanding surgical outcomes of perioperative durvalumab in AEGEAN study
Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented from ...
Sep 11, 2023
0
19